MoxDuo IR morphine/oxycodone regulatory update
FDA's Anesthetic and Analgesic Drug Products Advisory Committee voted 14-0 against approval of QRxPharma's MoxDuo IR morphine/oxycodone to treat moderate to severe acute pain. The
Gathering data...
FDA's Anesthetic and Analgesic Drug Products Advisory Committee voted 14-0 against approval of QRxPharma's MoxDuo IR morphine/oxycodone to treat moderate to severe acute pain. The